What changed
$UNH — WATCHLIST 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $111.7B | EPS $7.23 vs $6.60 🟢 | Margin 8.1%
💡 Consensus expects 10-12% annual EPS growth, which may be maintained. The beat is likely priced in, and the market underestimates regulatory uncertainties and slower Optum margin expansion. No variant view exists to drive near-term outperformance.
📉 Reward/risk: 2.0:1
🏢 Business Quality: 9/10 - Dominant market position, diversified revenue, consistent execution, and high barriers to entry.
📊 Valuation: fair — current P/E 30.2x is near the bottom of its narrow historical range (30.2-30.4x), but absolute multiple is high relative to healthcare peers.
🔮 Catalyst: Recent earnings beat is known. No imminent identifiable catalyst to shift valuation higher.
📊 Our read: WATCHLIST. Full analysis →
https://stockduty.xyz/s/UNH0621